
A provisional determination is also provided for the 40 mg/0.4 mL strength due to remaining interchangeability designation for another biosimilar to Humira.

A provisional determination is also provided for the 40 mg/0.4 mL strength due to remaining interchangeability designation for another biosimilar to Humira.

This is the first approval of an EB virus-related mRNA therapeutic cancer vaccine and is a landmark achievement in future research on cancer treatment.

Strategies for intervention design focused on opportunities for both patients and providers by way of medication labeling, specific prescription instructions, prescribing prompts, and educational services.


Investigators noted that the conditional overall survival also had clinically meaningful improvements compared with sorafenib for advanced renal cell carcinoma.

On this episode, Amie Stephens, Emilee Kennelly, and Max Baire, discuss social determinants of health and how they can impact patient outcomes and medication adherence.

As pharmacists continue to step into additional roles, culturally competent care becomes an even more essential part of their practices.

These developments highlight the dynamic landscape of health care innovation and the collaborative efforts driving progress in disease management and treatment.

The Rika system uses an individualized nomogram to help determine the plasma collection volume that is needed for each individual donor.

A clinical pharmacist discusses his work in the mental health space while stressing the importance of advocating for and checking in with one another’s emotional well-being.

With worsening news from accounting, where does community pharmacy go from here?

The results also showed that the PET scans could show damage to the individual’s brains, which was correlated with disability and fatigue.

This study is the first to preliminarily show that a community pharmacist intervention can produce a positive effect on reducing SABA reliance and improvement of ICS adherence in patients with asthma.

The ability to selectively silence or downregulate specific genes has opened new avenues for treating a myriad of diseases.

Community-based pharmacists performed mightily at a cost-efficient scale and safety record that rivaled any in the history of health professions.

This issue of Pharmacy Practice in Focus: Health Systems provides an overview of the considerations for the implementation of CRISPR and Cas9 cell-based gene therapies in sickle cell disease.

Tune into this episode of “Public Health Matters” to hear Dr. Kate Gainer’s journey in state pharmacy association and how advocacy and legislative initiatives can benefit pharmacists.

Multiple preparatory steps are involved in creating a delicious meal. Planning, preparation, and revision are similarly important in building a successful residency research program.

With the current social media trend of the “Sleepy-Girl Mocktail” claiming to provide quality sleep, is this trend fact or faux as a quality sleep aid?

This is the first FDA advisory committee meeting that will review a potential new posttraumatic stress disorder treatment in 25 years.

SMART uses an ICS and a long-acting beta-2 agonist (LABA) product, giving patients 4 years and older with moderate to severe uncontrolled persistent asthma 1 inhaler for dual symptom relief.

Ongoing and active shortages are currently at the highest number since January 2001.

The potential for RNAi to offer targeted and sustained control of blood pressure may represent a transformative approach in the broader landscape of cardiovascular therapeutics.

The vaccine protected against serotypes 19A and 19F, but statistical significance was not reached for serotype 3.

Compared with placebo, acalabrutinib plus standard of care chemoimmunotherapy demonstrated better progression-free survival in patients with mantle cell lymphoma.

As pharmacy practice continues to evolve, it is imperative to recognize the vital contributions of all members of the pharmacy team, including pharmacy technicians.

With gene therapy, anti-tissue factor pathway inhibitors, and RNA interference therapy targeting antithrombin, there are many new options that will be available for the patients impacted by hemophilia.

CAR T-cells specifically targeting FCRL5, when integrated with IL-15, may improve cytotoxicity, thereby enhancing the therapeutic potency of these cells.

The story of gepirone may spark new conversations for industry standards on drug development to facilitate future innovations.

In Iraq, asymmetrical warfare tactics relied heavily on unconventional weaponry, requiring military physicians to improvise new medical techniques in order to increase rates of survival.